CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Cengild Medical Bhd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Cengild Medical Bhd
Unit 2-3 & 2-4, Nexus @ Bangsar South
No. 7, Jalan Kerinchi
Phone: +60 322427000p:+60 322427000 KUALA LUMPUR, 59200  Malaysia Ticker: CENGILDCENGILD
Business Summary
Cengild Medical Berhad is a Malaysia-based investment holding company. The Company, through its subsidiary, is a healthcare provider specializing in the diagnosis and treatment of gastrointestinal and liver disease. The Company has around 36,588 sq. ft. medical center, which provides diagnostic and therapeutic facilities with 28 licensed beds, two fully equipped operating theatres, three endoscopy suites, and imaging facilities such as fibro scan, ultrasonography, computerized tomography (CT) scan, fluoroscopy, angiography equipment for endoscopic retrograde cholangiopancreatography (ERCP)s and other procedures. Its medical center's business activities comprise of consultant services and medical management services, which includes nursing services and clinical support services. In addition, it also offers 24-hour outpatient accident and emergency service, health screening, physiotherapy, and histopathology services. Its subsidiaries include Cengild Sdn. Bhd., and Galen Primer Sdn. Bhd.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/20246/30/2024Yes----

Industries
SIC Code Description
8062 General medical and surgical hospitals
8011 Offices and clinics of doctors of medicine
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board, Medical Director Huck JooTan 56 5/1/2021 2/3/2021
Group Chief Executive Officer Wai FernLee 48 11/1/2024 11/1/2024
Financial Controller Yoon Ahn L.Lian 37 9/10/2024 9/10/2024
9 additional Officers and Directors records available in full report.

General Information
Number of Employees: 159 (As of 6/30/2024)
Outstanding Shares: 832,912,600 (As of 6/30/2024)
Shareholders: 4,666
Stock Exchange: KUL
Fax Number: +60 327839111


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024